Pharma & Healthcare
Global Soft Tissue Sarcoma Targeted Drugs Market Research Report 2025
- Sep 24, 25
- ID: 520081
- Pages: 85
- Figures: 89
- Views: 4
This report aims to provide a comprehensive presentation of the global market for Soft Tissue Sarcoma Targeted Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Tissue Sarcoma Targeted Drugs.
The Soft Tissue Sarcoma Targeted Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soft Tissue Sarcoma Targeted Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soft Tissue Sarcoma Targeted Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Pfizer
Johnson & Johnson
GSK Plc
Teva Pharmaceuticals
Celgene
Bristol Myers Squibb
BeiGene
Shenzhen Chipscreen
Monopar Therapeutics
Akeso Biopharma
Segment by Type
Local Sarcoma
Metastatic Sarcoma
Other Sarcoma
Segment by Application
Hospitals
Oncology Centers
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soft Tissue Sarcoma Targeted Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Soft Tissue Sarcoma Targeted Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soft Tissue Sarcoma Targeted Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soft Tissue Sarcoma Targeted Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Pfizer
Johnson & Johnson
GSK Plc
Teva Pharmaceuticals
Celgene
Bristol Myers Squibb
BeiGene
Shenzhen Chipscreen
Monopar Therapeutics
Akeso Biopharma
Segment by Type
Local Sarcoma
Metastatic Sarcoma
Other Sarcoma
Segment by Application
Hospitals
Oncology Centers
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soft Tissue Sarcoma Targeted Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Local Sarcoma
1.2.3 Metastatic Sarcoma
1.2.4 Other Sarcoma
1.3 Market by Application
1.3.1 Global Soft Tissue Sarcoma Targeted Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Oncology Centers
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Perspective (2020-2031)
2.2 Global Soft Tissue Sarcoma Targeted Drugs Growth Trends by Region
2.2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Region (2020-2025)
2.2.3 Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Region (2026-2031)
2.3 Soft Tissue Sarcoma Targeted Drugs Market Dynamics
2.3.1 Soft Tissue Sarcoma Targeted Drugs Industry Trends
2.3.2 Soft Tissue Sarcoma Targeted Drugs Market Drivers
2.3.3 Soft Tissue Sarcoma Targeted Drugs Market Challenges
2.3.4 Soft Tissue Sarcoma Targeted Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Soft Tissue Sarcoma Targeted Drugs Players by Revenue
3.1.1 Global Top Soft Tissue Sarcoma Targeted Drugs Players by Revenue (2020-2025)
3.1.2 Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Soft Tissue Sarcoma Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Soft Tissue Sarcoma Targeted Drugs Revenue
3.4 Global Soft Tissue Sarcoma Targeted Drugs Market Concentration Ratio
3.4.1 Global Soft Tissue Sarcoma Targeted Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Tissue Sarcoma Targeted Drugs Revenue in 2024
3.5 Global Key Players of Soft Tissue Sarcoma Targeted Drugs Head office and Area Served
3.6 Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Product and Application
3.7 Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Soft Tissue Sarcoma Targeted Drugs Breakdown Data by Type
4.1 Global Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Type (2020-2025)
4.2 Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Type (2026-2031)
5 Soft Tissue Sarcoma Targeted Drugs Breakdown Data by Application
5.1 Global Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Application (2020-2025)
5.2 Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
6.2 North America Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
6.4 North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
7.2 Europe Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
7.4 Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
8.2 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
9.2 Latin America Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
9.4 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
10.2 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Soft Tissue Sarcoma Targeted Drugs Introduction
11.1.4 Roche Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Soft Tissue Sarcoma Targeted Drugs Introduction
11.2.4 Pfizer Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 GSK Plc
11.4.1 GSK Plc Company Details
11.4.2 GSK Plc Business Overview
11.4.3 GSK Plc Soft Tissue Sarcoma Targeted Drugs Introduction
11.4.4 GSK Plc Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.4.5 GSK Plc Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Introduction
11.5.4 Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Soft Tissue Sarcoma Targeted Drugs Introduction
11.6.4 Celgene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.6.5 Celgene Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Details
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Introduction
11.7.4 Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.7.5 Bristol Myers Squibb Recent Development
11.8 BeiGene
11.8.1 BeiGene Company Details
11.8.2 BeiGene Business Overview
11.8.3 BeiGene Soft Tissue Sarcoma Targeted Drugs Introduction
11.8.4 BeiGene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.8.5 BeiGene Recent Development
11.9 Shenzhen Chipscreen
11.9.1 Shenzhen Chipscreen Company Details
11.9.2 Shenzhen Chipscreen Business Overview
11.9.3 Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Introduction
11.9.4 Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.9.5 Shenzhen Chipscreen Recent Development
11.10 Monopar Therapeutics
11.10.1 Monopar Therapeutics Company Details
11.10.2 Monopar Therapeutics Business Overview
11.10.3 Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Introduction
11.10.4 Monopar Therapeutics Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.10.5 Monopar Therapeutics Recent Development
11.11 Akeso Biopharma
11.11.1 Akeso Biopharma Company Details
11.11.2 Akeso Biopharma Business Overview
11.11.3 Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Introduction
11.11.4 Akeso Biopharma Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.11.5 Akeso Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Local Sarcoma
1.2.3 Metastatic Sarcoma
1.2.4 Other Sarcoma
1.3 Market by Application
1.3.1 Global Soft Tissue Sarcoma Targeted Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Oncology Centers
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Perspective (2020-2031)
2.2 Global Soft Tissue Sarcoma Targeted Drugs Growth Trends by Region
2.2.1 Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Region (2020-2025)
2.2.3 Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Region (2026-2031)
2.3 Soft Tissue Sarcoma Targeted Drugs Market Dynamics
2.3.1 Soft Tissue Sarcoma Targeted Drugs Industry Trends
2.3.2 Soft Tissue Sarcoma Targeted Drugs Market Drivers
2.3.3 Soft Tissue Sarcoma Targeted Drugs Market Challenges
2.3.4 Soft Tissue Sarcoma Targeted Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Soft Tissue Sarcoma Targeted Drugs Players by Revenue
3.1.1 Global Top Soft Tissue Sarcoma Targeted Drugs Players by Revenue (2020-2025)
3.1.2 Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Soft Tissue Sarcoma Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Soft Tissue Sarcoma Targeted Drugs Revenue
3.4 Global Soft Tissue Sarcoma Targeted Drugs Market Concentration Ratio
3.4.1 Global Soft Tissue Sarcoma Targeted Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Tissue Sarcoma Targeted Drugs Revenue in 2024
3.5 Global Key Players of Soft Tissue Sarcoma Targeted Drugs Head office and Area Served
3.6 Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Product and Application
3.7 Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Soft Tissue Sarcoma Targeted Drugs Breakdown Data by Type
4.1 Global Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Type (2020-2025)
4.2 Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Type (2026-2031)
5 Soft Tissue Sarcoma Targeted Drugs Breakdown Data by Application
5.1 Global Soft Tissue Sarcoma Targeted Drugs Historic Market Size by Application (2020-2025)
5.2 Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
6.2 North America Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
6.4 North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
7.2 Europe Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
7.4 Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
8.2 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
9.2 Latin America Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
9.4 Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size (2020-2031)
10.2 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Soft Tissue Sarcoma Targeted Drugs Introduction
11.1.4 Roche Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Soft Tissue Sarcoma Targeted Drugs Introduction
11.2.4 Pfizer Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 GSK Plc
11.4.1 GSK Plc Company Details
11.4.2 GSK Plc Business Overview
11.4.3 GSK Plc Soft Tissue Sarcoma Targeted Drugs Introduction
11.4.4 GSK Plc Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.4.5 GSK Plc Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Introduction
11.5.4 Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Soft Tissue Sarcoma Targeted Drugs Introduction
11.6.4 Celgene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.6.5 Celgene Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Details
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Introduction
11.7.4 Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.7.5 Bristol Myers Squibb Recent Development
11.8 BeiGene
11.8.1 BeiGene Company Details
11.8.2 BeiGene Business Overview
11.8.3 BeiGene Soft Tissue Sarcoma Targeted Drugs Introduction
11.8.4 BeiGene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.8.5 BeiGene Recent Development
11.9 Shenzhen Chipscreen
11.9.1 Shenzhen Chipscreen Company Details
11.9.2 Shenzhen Chipscreen Business Overview
11.9.3 Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Introduction
11.9.4 Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.9.5 Shenzhen Chipscreen Recent Development
11.10 Monopar Therapeutics
11.10.1 Monopar Therapeutics Company Details
11.10.2 Monopar Therapeutics Business Overview
11.10.3 Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Introduction
11.10.4 Monopar Therapeutics Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.10.5 Monopar Therapeutics Recent Development
11.11 Akeso Biopharma
11.11.1 Akeso Biopharma Company Details
11.11.2 Akeso Biopharma Business Overview
11.11.3 Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Introduction
11.11.4 Akeso Biopharma Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
11.11.5 Akeso Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Local Sarcoma
Table 3. Key Players of Metastatic Sarcoma
Table 4. Key Players of Other Sarcoma
Table 5. Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2020-2025)
Table 9. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2026-2031)
Table 11. Soft Tissue Sarcoma Targeted Drugs Market Trends
Table 12. Soft Tissue Sarcoma Targeted Drugs Market Drivers
Table 13. Soft Tissue Sarcoma Targeted Drugs Market Challenges
Table 14. Soft Tissue Sarcoma Targeted Drugs Market Restraints
Table 15. Global Soft Tissue Sarcoma Targeted Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Players (2020-2025)
Table 17. Global Top Soft Tissue Sarcoma Targeted Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Targeted Drugs as of 2024)
Table 18. Ranking of Global Top Soft Tissue Sarcoma Targeted Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Soft Tissue Sarcoma Targeted Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Headquarters and Area Served
Table 21. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Product and Application
Table 22. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Soft Tissue Sarcoma Targeted Drugs Product
Table 50. Roche Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Soft Tissue Sarcoma Targeted Drugs Product
Table 55. Pfizer Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Product
Table 60. Johnson & Johnson Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. GSK Plc Company Details
Table 63. GSK Plc Business Overview
Table 64. GSK Plc Soft Tissue Sarcoma Targeted Drugs Product
Table 65. GSK Plc Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 66. GSK Plc Recent Development
Table 67. Teva Pharmaceuticals Company Details
Table 68. Teva Pharmaceuticals Business Overview
Table 69. Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Product
Table 70. Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 71. Teva Pharmaceuticals Recent Development
Table 72. Celgene Company Details
Table 73. Celgene Business Overview
Table 74. Celgene Soft Tissue Sarcoma Targeted Drugs Product
Table 75. Celgene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 76. Celgene Recent Development
Table 77. Bristol Myers Squibb Company Details
Table 78. Bristol Myers Squibb Business Overview
Table 79. Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Product
Table 80. Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 81. Bristol Myers Squibb Recent Development
Table 82. BeiGene Company Details
Table 83. BeiGene Business Overview
Table 84. BeiGene Soft Tissue Sarcoma Targeted Drugs Product
Table 85. BeiGene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 86. BeiGene Recent Development
Table 87. Shenzhen Chipscreen Company Details
Table 88. Shenzhen Chipscreen Business Overview
Table 89. Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Product
Table 90. Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 91. Shenzhen Chipscreen Recent Development
Table 92. Monopar Therapeutics Company Details
Table 93. Monopar Therapeutics Business Overview
Table 94. Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Product
Table 95. Monopar Therapeutics Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 96. Monopar Therapeutics Recent Development
Table 97. Akeso Biopharma Company Details
Table 98. Akeso Biopharma Business Overview
Table 99. Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Product
Table 100. Akeso Biopharma Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 101. Akeso Biopharma Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Soft Tissue Sarcoma Targeted Drugs Picture
Figure 2. Global Soft Tissue Sarcoma Targeted Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Type: 2024 VS 2031
Figure 4. Local Sarcoma Features
Figure 5. Metastatic Sarcoma Features
Figure 6. Other Sarcoma Features
Figure 7. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Oncology Centers Case Studies
Figure 11. Other Case Studies
Figure 12. Soft Tissue Sarcoma Targeted Drugs Report Years Considered
Figure 13. Global Soft Tissue Sarcoma Targeted Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Soft Tissue Sarcoma Targeted Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Players in 2024
Figure 17. Global Top Soft Tissue Sarcoma Targeted Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Targeted Drugs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Soft Tissue Sarcoma Targeted Drugs Revenue in 2024
Figure 19. North America Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 21. United States Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 25. Germany Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2020-2031)
Figure 33. China Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 41. Mexico Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 45. Turkey Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 51. GSK Plc Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 53. Celgene Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 54. Bristol Myers Squibb Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 55. BeiGene Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 56. Shenzhen Chipscreen Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 57. Monopar Therapeutics Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 58. Akeso Biopharma Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Local Sarcoma
Table 3. Key Players of Metastatic Sarcoma
Table 4. Key Players of Other Sarcoma
Table 5. Global Soft Tissue Sarcoma Targeted Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2020-2025)
Table 9. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2026-2031)
Table 11. Soft Tissue Sarcoma Targeted Drugs Market Trends
Table 12. Soft Tissue Sarcoma Targeted Drugs Market Drivers
Table 13. Soft Tissue Sarcoma Targeted Drugs Market Challenges
Table 14. Soft Tissue Sarcoma Targeted Drugs Market Restraints
Table 15. Global Soft Tissue Sarcoma Targeted Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Players (2020-2025)
Table 17. Global Top Soft Tissue Sarcoma Targeted Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Targeted Drugs as of 2024)
Table 18. Ranking of Global Top Soft Tissue Sarcoma Targeted Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Soft Tissue Sarcoma Targeted Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Headquarters and Area Served
Table 21. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Product and Application
Table 22. Global Key Players of Soft Tissue Sarcoma Targeted Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Soft Tissue Sarcoma Targeted Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Soft Tissue Sarcoma Targeted Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Soft Tissue Sarcoma Targeted Drugs Product
Table 50. Roche Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Soft Tissue Sarcoma Targeted Drugs Product
Table 55. Pfizer Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Soft Tissue Sarcoma Targeted Drugs Product
Table 60. Johnson & Johnson Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. GSK Plc Company Details
Table 63. GSK Plc Business Overview
Table 64. GSK Plc Soft Tissue Sarcoma Targeted Drugs Product
Table 65. GSK Plc Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 66. GSK Plc Recent Development
Table 67. Teva Pharmaceuticals Company Details
Table 68. Teva Pharmaceuticals Business Overview
Table 69. Teva Pharmaceuticals Soft Tissue Sarcoma Targeted Drugs Product
Table 70. Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 71. Teva Pharmaceuticals Recent Development
Table 72. Celgene Company Details
Table 73. Celgene Business Overview
Table 74. Celgene Soft Tissue Sarcoma Targeted Drugs Product
Table 75. Celgene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 76. Celgene Recent Development
Table 77. Bristol Myers Squibb Company Details
Table 78. Bristol Myers Squibb Business Overview
Table 79. Bristol Myers Squibb Soft Tissue Sarcoma Targeted Drugs Product
Table 80. Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 81. Bristol Myers Squibb Recent Development
Table 82. BeiGene Company Details
Table 83. BeiGene Business Overview
Table 84. BeiGene Soft Tissue Sarcoma Targeted Drugs Product
Table 85. BeiGene Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 86. BeiGene Recent Development
Table 87. Shenzhen Chipscreen Company Details
Table 88. Shenzhen Chipscreen Business Overview
Table 89. Shenzhen Chipscreen Soft Tissue Sarcoma Targeted Drugs Product
Table 90. Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 91. Shenzhen Chipscreen Recent Development
Table 92. Monopar Therapeutics Company Details
Table 93. Monopar Therapeutics Business Overview
Table 94. Monopar Therapeutics Soft Tissue Sarcoma Targeted Drugs Product
Table 95. Monopar Therapeutics Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 96. Monopar Therapeutics Recent Development
Table 97. Akeso Biopharma Company Details
Table 98. Akeso Biopharma Business Overview
Table 99. Akeso Biopharma Soft Tissue Sarcoma Targeted Drugs Product
Table 100. Akeso Biopharma Revenue in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025) & (US$ Million)
Table 101. Akeso Biopharma Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Soft Tissue Sarcoma Targeted Drugs Picture
Figure 2. Global Soft Tissue Sarcoma Targeted Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Type: 2024 VS 2031
Figure 4. Local Sarcoma Features
Figure 5. Metastatic Sarcoma Features
Figure 6. Other Sarcoma Features
Figure 7. Global Soft Tissue Sarcoma Targeted Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Oncology Centers Case Studies
Figure 11. Other Case Studies
Figure 12. Soft Tissue Sarcoma Targeted Drugs Report Years Considered
Figure 13. Global Soft Tissue Sarcoma Targeted Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Soft Tissue Sarcoma Targeted Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global Soft Tissue Sarcoma Targeted Drugs Market Share by Players in 2024
Figure 17. Global Top Soft Tissue Sarcoma Targeted Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Targeted Drugs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Soft Tissue Sarcoma Targeted Drugs Revenue in 2024
Figure 19. North America Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 21. United States Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 25. Germany Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Soft Tissue Sarcoma Targeted Drugs Market Share by Region (2020-2031)
Figure 33. China Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 41. Mexico Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Soft Tissue Sarcoma Targeted Drugs Market Share by Country (2020-2031)
Figure 45. Turkey Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Soft Tissue Sarcoma Targeted Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 51. GSK Plc Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 53. Celgene Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 54. Bristol Myers Squibb Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 55. BeiGene Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 56. Shenzhen Chipscreen Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 57. Monopar Therapeutics Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 58. Akeso Biopharma Revenue Growth Rate in Soft Tissue Sarcoma Targeted Drugs Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232